Current Valuation
N/A
As of August 1, 2024
Total Funding Raised
$2.2M
Last Round
Grant

$2.0M

Last Funding
Aug 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

EVOQ Therapeutics is currently valued at N/A as of August 1, 2024. The company has raised a total of $2.2M in funding.

Investment Perspective

EVOQ Therapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track EVOQ Therapeutics Valuation Updates

Get notified when EVOQ Therapeutics raises new funding or valuation changes

What is EVOQ Therapeutics Worth in 2025?

As of 2025, EVOQ Therapeutics is valued at N/A, based on the company's Grant funding round in August 1, 2024. This valuation positions EVOQ Therapeutics as one of the leading private companies in the sector.

EVOQ Therapeutics Valuation History

EVOQ Therapeutics's funding history demonstrates steady growth and investor confidence.

How EVOQ Therapeutics Valuation is Determined

Private company valuations like EVOQ Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

EVOQ Therapeutics Valuation FAQs

Is EVOQ Therapeutics profitable?

EVOQ Therapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does EVOQ Therapeutics's valuation compare to competitors?

EVOQ Therapeutics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will EVOQ Therapeutics IPO?

EVOQ Therapeutics has not announced plans for an initial public offering. Until an IPO, investors can access EVOQ Therapeutics shares through secondary market platforms.